The Al Nabhani Lab studies how microbe-immune interplay during weaning influences lifelong host health. They are generating new therapies to treat autoimmunity, obesity, intestinal inflammation and neurodegenerative disorders.
The Al Nabhani Lab studies how microbe-immune interplay during weaning influences lifelong host health. They are generating new therapies to treat autoimmunity, obesity, intestinal inflammation and neurodegenerative disorders.